Kesmalea Therapeutics
Pre-clinicalDevelops novel immunotherapies targeting cancer resistance mechanisms.
Founded
2021
Focus
OncologyImmunology
About
Develops novel immunotherapies targeting cancer resistance mechanisms.
Company Info
TypePrivate
Founded2021
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile